Summary & Overview
HCPCS G9384: Documentation of Medical Exclusion from HCV Screening
HCPCS Level II code G9384 denotes documentation of a medical reason for not receiving annual hepatitis C virus (HCV) screening. This code matters nationally because it standardizes capture of clinically justified exclusions from routine HCV screening, affecting preventive care reporting and quality measurement for populations with advanced liver disease, terminal illness, or transplant candidacy. Clear documentation supports care continuity and accurate quality metrics.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, common use cases (advanced liver disease, hepatocellular carcinoma, transplant waitlist, limited life expectancy), and the typical sites where documentation occurs. The publication outlines benchmarking and reporting implications, relevant billing considerations, and where G9384 intersects with quality measurement and preventive care workflows. It also summarizes common modifiers and payor considerations when available.
This summary is intended for national audiences including clinicians, coding and billing staff, quality leaders, and policy analysts seeking a concise reference on the purpose and reporting implications of HCPCS Level II code G9384. Data not available in the input is identified where applicable.
Billing Code Overview
HCPCS Level II code G9384 documents a medical reason for not receiving annual screening for hepatitis C virus (HCV) infection. The code captures clinician-documented conditions that justify omission of routine HCV screening, such as decompensated cirrhosis with manifestations (ascites, esophageal variceal bleeding, hepatic encephalopathy), hepatocellular carcinoma, being on a waitlist for organ transplant, limited life expectancy, or other medical reasons.
Service type: Documentation of medical exclusion from preventive screening
Typical site of service: Inpatient and outpatient clinical settings where documentation of screening decisions is made, including hospitals, specialty hepatology clinics, transplant centers, and primary care clinics.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with known decompensated cirrhosis due to chronic hepatitis C is seen in hepatology clinic for routine follow-up. The patient has refractory ascites, prior esophageal variceal bleeding, and stage 3 hepatic encephalopathy with frequent hospitalizations. The clinician documents that annual HCV screening or repeat HCV RNA testing is medically inappropriate because the patient has advanced liver disease with limited life expectancy and is on the transplant waitlist with clear documentation that further HCV screening will not alter management. The documentation is entered into the medical record, signed by the attending hepatologist, and coded with G9384 to indicate the medical reason for not performing the annual HCV screening.
Workflow steps:
-
Initial evaluation identifies patient with advanced liver disease and prior HCV diagnosis or clear clinical indications that screening will not change care.
-
Clinician documents the specific medical reason(s) (e.g., decompensated cirrhosis with ascites, history of variceal bleed, hepatic encephalopathy, hepatocellular carcinoma, transplant waitlist status, or limited life expectancy).
-
Documentation is placed in the visit note and problem list, including supporting findings (imaging, MELD score, transplant status, prior HCC diagnosis).
-
Coding/billing staff assign
G9384on the claim to indicate documentation of medical reason(s) for not performing the annual HCV screening. -
The claim is submitted to the relevant payor (e.g., Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, Medicare) with any applicable modifiers as needed for the encounter.